XWELL Inc

XWELL Inc (XWEL) Stock Analysis

$0.589

+0.016 (+2.78%)At close

Loading chart…
High
0.589
Open
0.560
VWAP
0.58
Volume
16.99K
Mkt Cap
7.36M
Low
0.560
Amount
9.84K
EV/EBITDA, TTM
0.00

XWELL, Inc. is a global wellness company. The Company delivers restorative and health-focused services to travelers through its three operating segments: XpresSpa, XpresTest, and Naples Wax Center. XpresSpa operates spa service locations in major airports, offering massage, skincare, and travel products. The XpresTest segment provides aircraft wastewater and passenger nasal sampling through the Centers for Disease Control and Prevention's (CDC's) bio-surveillance program. The Naples Wax Center segment operates six locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products. Its health wellness beauty services include massage, waxing, facials, stretch, light emitting diode (LED) light therapy, meditation, manicures, pedicures, aromatherapy, anti-aging treatments, compression therapy, and massage chairs. Its subsidiaries include Naples Wax FRM LLC, Quantum Stream Inc., XpresSpa Holdings, LLC, XpresTest, Inc., and others.

www.xwell.com

AI analysis of XWELL Inc (XWEL)

Sell

XWELL Inc is not a good buy right now due to its declining financial performance and negative market sentiment. The stock has a current price of $0.59, which is significantly lower than its 52-week high of $2.20, indicating a 73% drop from its peak. Additionally, the RSI is at 28.253, suggesting the stock is oversold, but this does not guarantee a rebound. The company reported a net loss of $22.4 million in Q2 2026, which raises concerns about its profitability. The stock has also seen a 14.72% drop over the last five days, reflecting ongoing negative sentiment.

Valuation Metrics

The current forward P/E ratio for XWELL Inc (XWEL) is 10.79, compared to its 5-year average forward P/E of 0.23.

Forward P/E

Strongly Overvalued
5Y Average P/E
0.23
Current P/E
10.79
Overvalued
4.95
Undervalued
-4.48

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-1.28
Current EV/EBITDA
0.00
Overvalued
0.40
Undervalued
-2.96

Forward P/S

Fair
5Y Average P/S
0.66
Current P/S
0.00
Overvalued
1.33
Undervalued
-0.01

Events Timeline

2026-07-07 (ET)

09:30:00

Xwell Divests XpresSpa and XpresTest for $13M

2026-04-01 (ET)

16:40:00

XWELL CEO Emphasizes Brand Relevance and Market Expansion

2026-02-03 (ET)

08:30:00

Xwell Partners with PieQ for Biosecurity Forecasting Platform

2026-01-08 (ET)

08:30:00

XWELL Expands Global Biosecurity Strategy, Appoints Former CDC Advisor as Senior Advisor

2025-12-18 (ET)

08:20:00

XWELL Opens New Location in New York's Pennsylvania Station

News

XWEL FAQ — answered by Alphio AI

XWELL, Inc. is a global wellness company. The Company delivers restorative and health-focused services to travelers through its three operating segments: XpresSpa, XpresTest, and Naples Wax Center. XpresSpa operates spa service locations in major airports, offering massage, skincare, and travel products. The XpresTest segment provides aircraft wastewater and passenger nasal sampling through the Centers for Disease Control and Prevention's (CDC's) bio-surveillance program. The Naples Wax Center segment operates six locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products. Its health wellness beauty services include massage, waxing, facials, stretch, light emitting diode (LED) light therapy, meditation, manicures, pedicures, aromatherapy, anti-aging treatments, compression therapy, and massage chairs. Its subsidiaries include Naples Wax FRM LLC, Quantum Stream Inc., XpresSpa Holdings, LLC, XpresTest, Inc., and others. It operates in the Consumer Non-Cyclicals sector (SERVICES-PERSONAL SERVICES industry).

XWELL Inc is not a good buy right now due to its declining financial performance and negative market sentiment. The stock has a current price of $0.59, which is significantly lower than its 52-week high of $2.20, indicating a 73% drop from its peak. Additionally, the RSI is at 28.253, suggesting the stock is oversold, but this does not guarantee a rebound. The company reported a net loss of $22.4 million in Q2 2026, which raises concerns about its profitability. The stock has also seen a 14.72% drop over the last five days, reflecting ongoing negative sentiment.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading